Eli Lilly and Co (LLY)

139.58 -1.85  -1.31% NYSE Jan 17, 20:00 Delayed 2m USD

Eli Lilly Cash from Financing (TTM):

-2.851B for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 -2.851B
June 30, 2019 -725.00M
March 31, 2019 -670.60M
Dec. 31, 2018 -5.905B
Sept. 30, 2018 -4.808B
June 30, 2018 -4.740B
March 31, 2018 -2.848B
Dec. 31, 2017 142.60M
Sept. 30, 2017 1.070B
June 30, 2017 -30.70M
March 31, 2017 -511.30M
Dec. 31, 2016 -559.80M
Sept. 30, 2016 -1.816B
June 30, 2016 -1.812B
March 31, 2016 -3.334B
Dec. 31, 2015 -3.111B
Sept. 30, 2015 -702.50M
June 30, 2015 -513.20M
March 31, 2015 -272.50M
Dec. 31, 2014 -166.40M
Sept. 30, 2014 -2.740B
June 30, 2014 -2.863B
March 31, 2014 -2.694B
Dec. 31, 2013 -3.829B
Sept. 30, 2013 -4.058B
   
June 30, 2013 -4.074B
March 31, 2013 -4.093B
Dec. 31, 2012 -4.420B
Sept. 30, 2012 -3.805B
June 30, 2012 -3.702B
March 31, 2012 -3.713B
Dec. 31, 2011 -2.370B
Sept. 30, 2011 -2.269B
June 30, 2011 -2.222B
March 31, 2011 -2.189B
Dec. 31, 2010 -2.022B
Sept. 30, 2010 -2.601B
June 30, 2010 -3.120B
March 31, 2010 -3.700B
Dec. 31, 2009 -5.534B
Sept. 30, 2009 -108.00M
June 30, 2009 239.40M
March 31, 2009 827.50M
Dec. 31, 2008 2.346B
Sept. 30, 2008 -2.442B
June 30, 2008 -2.449B
March 31, 2008 -2.650B
Dec. 31, 2007 -844.90M
Sept. 30, 2007 -1.959B
June 30, 2007 -3.292B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

Cash from Financing (TTM) Benchmarks

Benchmarks
Amgen Inc -17.41B
Biogen Inc -5.181B
Gilead Sciences Inc -8.408B

Cash from Financing (TTM) Range, Past 5 Years

Minimum -5.905B Dec 2018
Maximum 1.070B Sep 2017
Average -1.789B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.